-+undefined NaN%
-+undefined NaN%
-+undefined NaN%

Dawson James Initiates Coverage On Zomedica with Buy Rating, Announces Price Target of $6

Benzinga · 01/06/2023 08:25
Dawson James analyst Jason Kolbert initiates coverage on Zomedica (AMEX:ZOM) with a Buy rating and announces Price Target of $6.